不完全性系统性红斑狼疮:ACR与SLICC标准应用后的残留问题
本文综述了不完全性系统性红斑狼疮(iSLE)在应用ACR和SLICC分类标准后的临床特征,指出部分iSLE患者有持续轻度疾病,另一些则有严重器官受累,高达55%进展为确诊SLE。文章提出iSLE的定义以区分高风险组,并建议对高风险患者早期治疗,但需随机对照试验确认。
要点
- iSLE患者中高达55%进展为确诊SLE,部分有严重器官受累。
- SLICC分类标准旨在更早诊断SLE,本文综述应用后iSLE的临床特征。
- 提出iSLE定义以区分高风险组,建议早期治疗但需随机对照试验验证。
核心结论
- iSLE是未满足SLE分类标准但有狼疮临床征象的病症,部分患者有严重器官受累或进展为SLE的高风险。
研究设计与样本
- 本文为综述,概述应用SLICC分类标准后iSLE的临床特征并提出定义。
主要发现
- 部分iSLE患者有持续轻度疾病,另一些有严重器官受累,高达55%进展为确诊SLE。
关键数值与推荐
- SLICC分类标准旨在更早诊断SLE,本文提出iSLE定义以区分高风险组与低风险组。
临床怎么用
- 高风险iSLE患者可能受益于早期治疗,但需随机对照试验确认。
局限性
- 需就iSLE定义达成一致,早期治疗的获益需随机对照试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Incomplete systemic lupus (iSLE) is an acknowledged condition of patients with clinical signs of lupus who do not fulfill classification criteria for SLE. Some patients with iSLE have persistent mild disease, but others have serious organ involvement, and up to 55% progress to established SLE. Research on this subject could reveal predictive or diagnostic biomarkers for SLE. Ideally, it would become possible to discern those patients with critical organ involvement or a high risk for progression to SLE. This high-risk group might benefit from early treatment, which would preferably be confirmed in randomized controlled trials. This process would, however, require agreement on a definition of iSLE. The Systemic Lupus International Collaborating Clinics (SLICC) classification criteria was composed in order to diagnose SLE earlier. The present review outlines the clinical characteristics of iSLE after introduction of SLICC criteria and furthermore proposes a definition of iSLE with the aim of discriminating the high-risk group from those with a lower risk.
引用
- Lambers WM, Westra J, Jonkman MF, et al. Incomplete Systemic Lupus Erythematosus: What Remains After Application of American College of Rheumatology and Systemic Lupus International Collaborating Clinics criteria? Arthritis Care Res (Hoboken). 2020. PMID: 30932354. doi:10.1002/acr.23894
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。